Journal of Antimicrobial Chemotherapy · 2014 · 44 citations · 17 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceBacteriologyMolecular EpidemiologyAntibiotic ResistanceBacterial EpidemiologyBacterial InfectionsCarbapenem ResistanceMolecular Epidemiology Of ResistanceResistance EpidemiologyAcinetobacter Baumannii ResistanceAminoglycoside-modifying EnzymesExtended-spectrum Beta-lactamasesMolecular Typing Of BacteriaMolecular Typing Of Resistant IsolatesMultiplex Polymerase Chain Reaction (Pcr)Resistance Gene MechanismsResistance In Clinical Isolates
OBJECTIVES: We examined the molecular epidemiology of Acinetobacter baumannii clinical isolates from two cities (Tehran and Tabriz) of Iran. METHODS: DiversiLab repetitive extragenic palindromic PCR (rep-PCR), multilocus sequence typing and sequence group multiplex PCR were performed. The presence of resistance mechanisms including metallo-β-lactamases, extended-spectrum β-lactamases, OXA carbapenemases, aminoglycoside-modifying enzymes and RNA methylases was also investigated. RESULTS: DiversiLab rep-PCR identified 11 clusters and 11 singleton isolates. Twelve sequence types (STs), including six novel types, were identified. Sequence groups (SGs) 1-3 as well as five additional banding patterns were detected by multiplex PCR. A local outbreak in a general hospital in Tabriz with an SG1/ST2 profile was identified. Isolates of international clone II showed the highest prevalence and the most heterogeneous combination of resistance determinants. CONCLUSIONS: Several different multiresistant strains of A. baumannii were shown to circulate in Iran. The selection and spread of the SG1/ST2 clone might have been favoured by the acquisition of resistance genes in the absence of adequate infection control measures.
17
Jane F. Turton, Neil Woodford, Judith Glover et al. · Journal of Clinical Microbiology · 2006 · 645 citations · Full text
Paul T. Scott, Gregory A. Deye, Ashish Srinivasan et al. · Clinical Infectious Diseases · 2007 · 393 citations